medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2007, Number 3

<< Back Next >>

Ann Hepatol 2007; 6 (3)

Hepatopulmonary syndrome - Past to present

Varghese J, Ilias-basha H, Dhanasekaran R, Singh S, Venkataraman J

Language: English
References: 104
Page: 135-142
PDF size: 162.69 Kb.


ABSTRACT

Hepatopulmonary syndrome (HPS) is the one of the complication of liver cirrhosis with portal hypertension, irrespective of etiology, age and sex. It has also been observed in non cirrhotic portal hypertension and in acute hepatic conditions. Presence of hypoxemia or abnormal alveolar arterial oxygen tension with intrapulmonary vasodilation in liver cirrhosis is termed as HPS. Contrast echocardiogram is the better screening tool to demonstrate intrapulmonary shunt. Clinicians should be aware of other common chronic pulmonary and cardiac comorbid conditions, in particular COPD, tuberculosis, bronchial asthma and idiopathic pulmonary fibrosis, etc. which may coexist with HPS. There is no specific clinical finding to diagnose but digital clubbing, cyanosis, dyspnoea, platypnoea, and spider naevi are more common among cirrhosis with HPS. The presence of HPS independently worsens prognosis of cirrhosis. Even though number of mechanisms have been proposed to explain arterial hypoxemia in HPS, role of nitric oxide is the major one along with cytokines. Liver transplantation is the choice of treatment though mortality is comparatively high. There is no still effective recommended medical therapy to reverse this condition and anti cytokine/ nitric oxide inhibitors, etc are under preliminary stage.


REFERENCES

  1. Mazzeo AT, Bottari G, Pratico C, Penna O, Mandolfino T, Santamaria LB. Significance of hypoxemia screening in candidates for liver transplantation: our experience. Transplant Proc 2006; 38(3): 793-794.

  2. Allgaier HP, Haag K, Blum HE. Hepatopulmonary syndrome. Z Gastroenterol 1998; 36(3): 247-251.

  3. Fluckiger M. Vorkommen von trommelschlägelförmigen fingerendphalangen ohne chronische veränderungen an der lungen oder am herzen. Wien Med Wschr 1884; 34: 1457.

  4. Kennedy TC, Knudson RJ. Exercise aggravated hypoxemia and orthodeoxia in cirrhosis. Chest 1997; 72: 305-319.

  5. Dollinger MM. Pulmonary complication in liver disease. Schweiz Rundsch Med Prax 2006; 95(40): 1539-1542.

  6. Krowka MJ, Tajik AJ, Dickson ER, Wiesner RH, Cortese DA. Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates: screening by two-dimensional contrast-enhanced echocardiography. Chest 1990; 97: 1165-1170.

  7. Stoller J, Lange P, Westveer M, Carey W, Vogt D, Henderson M. Prevalence and reversibility of the hepatopulmonary syndrome after liver transplantation–the Cleveland Clinic experience. West J Med 1995; 163(2): 133-138.

  8. Abrams GA, Jaffe CC, Hoffer PB, Binder HJ, Fallon MB. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology 1995; 109: 1283-1288.

  9. Stoller JK, Moodie D, Schiavone WA. Reduction of intrapulmonary shunt and resolution of digital clubbing associated with primary biliary cirrhosis after liver transplantation. Hepatology 1990; 11(1): 54-58.

  10. Lange PA, Stoller JK. The hepatopulmonary syndrome. Ann Intern Med 1995; 122: 521-529.

  11. Schenk P, Fuhrmann V, Madl C, Funk G, Lehr S, Kandel O, Muller C. Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut 2002; 51: 853-859.

  12. Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB. Pulmonary-Hepatic vascular Disorders. Eur Respir J 2004; 24: 861-880.

  13. Martinez G, Barbera J, Navasa M, Roca J, Visa J, Rodriguez- Roisin R. Hepatopulmonary syndrome associated with cardiorespiratory disease. J Hepatol 1999; 30: 882-889.

  14. Abrams G, Nanda N, Dubovsky E, Krowka M, Fallon M. Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology 1998; 114: 305-310.

  15. Harris E, Kenyon A, Nisbet H, Seelye E, Whitlock R. The normal alveolar-arterial oxygen-tension gradient in man. Clin Sci Mol Med 1974; 46: 89-104.

  16. Silverman A, Cooper MD, Moller JH, Good RA. Syndrome of cyanosis, digital clubbing, and hepatic disease in siblings. J Pediatr 1968; 72: 70-80.

  17. Crary GS, Burke BA, Alford BA, du Cret RP, Wood BP. Radiological cases of the month. Pulmonary arteriovenous shunting in a child with cirrhosis of the liver. Am J Dis Child 1989; 143: 749-751.

  18. Krowka MJ, Mandell MS, Ramsay MA, et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl 2004; 10(2): 174-182.

  19. Jiva TM. Unexplained hypoxemia in liver disease: The hepatopulmonary syndrome. J Crit Illness 1994; 9(10): 934-47.

  20. Bruix J, Bosch J, Kravetz D, et al. Effects of prostaglandin inhibition on systemic and hepatic hemodynamics in patients with cirrhosis of the liver. Gastroenterology 1985; 88: 430-435.

  21. Pizcueta P, Pique JM, Fernandez M, et al. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992; 103: 1909-15.

  22. Henriksen JH, Staun-Olsen P, Fahrenkrug P, et al. Vasoactive intestinal polypeptide in cirrhosis Arteriovenous extraction in different vascular beds. Scand J Gastroenterol 1980; 15: 787-792.

  23. Krowka MJ, Cortese DA. Hepatopulmonary syndrome: an evolving perspective in the era of liver transplantation. Hepatology 1990; 11: 138-142.

  24. Macro J, Diego J, Vilanueva ML, et al. Elavated plasma glycogen levels in cirrhosis of the liver. N Engl J Med 1973; 289: 1107-1111.

  25. Hortnagl H, Singer EA, Lenz K, et al. Substance-P is markedly increased in plasma of patients with hepatic coma. Lancet 1984; 1: 480-483.

  26. Gines P, Jimenez W, Arroyo V, et al. Atrial natriuretic factor in cirrhosis with ascites: Plasma levels, cardial release and splanchnic extraction. Hepatology 1988; 8: 636-642.

  27. Krowka M, Wiseman G, Burnett O, Spivey J, Therneau T, Porayko M, Wiesner R. Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO2 response to 100% oxygen, and brain uptake after 99mTc MAA lung scanning. Chest 2000; 118: 615-624.

  28. Whyte M, Hughes J, Peters A, Ussov W, Patel S, Burroughs A. Analysis of intra pulmonary right to left shunt in hepatopulmonary syndrome. J Hepatol 1998; 29: 85-93.

  29. Dimand RJ, Heyman MB, Bass NM, Lavine JE, Lake JR, Roberts JP. Hepatopulmonary syndrome: response to hepatic transplantation. Hepatology 1991; 141: 155.

  30. Abrams G, Fallon M. Hepatopulmonary syndrome. Clin Liver Dis 1997; 1: 185-200.

  31. Binay K, Sen S, Biswas PK, Sanyal R, Jumdar DM, Biswas J. Hepatopulmonary syndrome in inferior vena cava obstruction responding to cavoplasty. Gastroenterology 2000; 118: 192-196.

  32. Gupta D, Vijaya DR, Gupta R, Dhiman RK, Bhargava M, Verma J. Prevalence of hepatopulmonary syndrome in cirrhosis and extrahepatic portal venous obstruction. Am J Gastroenterol 2001; 96: 3395-3399.

  33. Regev A, Yeshurun M, Rodriguez M, Sagie A, Neff G, Molina E. Transient hepatopulmonary syndrome in a patient with acute hepatitis A. J Viral Hep 2001; 8: 83-86.

  34. Teuber G, Teupe C, Dietrich C, Caspary W, Buhl R, Zeuzem S. Pulmonary dysfunction in non-cirrhotic patients with chronic viral hepatitis. Eur J Intern Med 2002; 13: 311-318.

  35. Lange PA, Stoller JK. The Hepatopulmonary Syndrome. Annals of Internal Medicine 1995; 122: 521-529.

  36. Keys A, Snell AM. Respiratory properties of the arterial blood in normal man and in patients with disease of the liver: Position of the oxygen dissociation curve. J Clin Invest 1938; 17: 59-67.

  37. Caldwell PR, Fritts HW, Cournard A. Oxyhemoglobin dissociation curve in liver disease. J Appl Physiol 1965; 20: 316-20.

  38. Astrup J, Rorth M. Oxygen affinity of hemoglobin and red cell 2,3-diphosphoglycerate in hepatic cirrhosis. Scand J Clin Lab Invest 1973; 31: 311-317.

  39. Krowka MJ, Cortese DA. Hepatopulmonary syndrome (Editorial). Chest 1990; 98: 1053-1054.

  40. Hedenstierna G, Soderman C, Eriksson LS, Wahren J. Ventilation-perfusion inequality in patients with non-alcoholic liver cirrhosis. Eur Respir J 1991; 4: 711-717.

  41. Davis HH 2d, Schwartz DJ, Lefrak SS, Susman N, Schainker BA. Alveolar-capillary oxygen disequilibrium in hepatic cirrhosis. Chest 1978; 73: 507-511.

  42. Calabresi P, Abelmann WH. Portocaval and porto-pulmonary anastomoses in Laennec’s cirrhosis and in heart failure. J Clin Invest 1957; 36: 1257-1265.

  43. Ruff F, Hughes JM, Stanley N, McCarthy D, Greene R, Aronoff A, et al. Regional lung function in patients with hepatic cirrhosis. J Clin Invest 1971; 50: 2403-2413.

  44. Daoud FS, Reeves JT, Schaefer JW. Failure of hypoxic pulmonary vasoconstriction in patients in patients with liver cirrhosis. J Clin Invest 1972; 51: 1076-1080.

  45. Naeije R, Hallemans R, Mols P, Melot C. Hypoxic pulmonary vasoconstriction in liver cirrhosis. Chest 1981; 80: 570-574.

  46. Kobayashi S, Aida A, Aio K, Nishimura M, Kawakami Y. Liver cirrhosis with severe hypoxemia and paradoxic pulmonary vascular response to graded inspiratory oxygen tension. Chest 1993; 103: 958-960.

  47. Melot C, Naeije R, Dechamps P, Hallemans R, Lejeune P. Pulmonary and extrapulmonary contributors to hypoxemia in liver cirrhosis. Am Rev Respir Dis 1989; 139: 632-640.

  48. Gomez F, Barbera J, Roca J, Burgos F, Gistau C, Rodriguez-Roisin R. Effects of nebulized NG-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome. Hepatology 2006; 43: 1084-1091.

  49. Dinh-Xuan AT. Endothelial modulation of pulmonary vascular tone. Eur Respir J 1992; 5: 757-762.

  50. Rolla G, Brussino L, Colagrande P, et al. Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis. Hepatology 1997; 26: 842–847.

  51. Rolla G, Brussino L, Colagrande P. Exhaled nitric oxide and impaired oxygenation in cirrhotic patients before and after liver transplantation. Ann Intern Med 1998; 129: 375-8.

  52. Cremona G, Higenbottam TW, Mayoral V, Alexander G, Demoncheaux E, Borland C, Roe P, Jones GJ. Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome. Eur Respir J 1995; 8: 1883-1885.

  53. Delclaux C, Mahut B, Zerah-Lancner F, et al. Increased nitric oxide output from alveolar origin during liver cirrhosis versus bronchial source during asthma. Am J Respir Crit Care Med 2002; 165: 332-337.

  54. Nunes H, Lebrec D, Mazmanian M, et al. Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. Am J Respir Crit Care Med 2001; 164: 879-885.

  55. Zhang J, Ling Y, Luo B, et al. Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome. Gastroenterology 2003; 125: 1441-1451.

  56. Rolla G, Bucca C, Brussino L. Methylene blue in the hepatopulmonary syndrome. N Engl J Med 1994; 331: 1098.

  57. Brussino L, Bucca C, Morello M, Scappaticci E, Mauro M, Rolla G. Effect on dyspnoea and hypoxaemia of inhaled NG-nitro-Larginine methyl ester in hepatopulmonary syndrome. Lancet 2003; 362: 43-44.

  58. Schenk P, Madl C, Rezale-Majd S, Lehr S, Muller C. Methylene blue improves the hepatopulmonary syndrome. Ann Int Med 2000; 133: 701-706.

  59. Jia L, Bonaventura J, Stamler JS. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996; 380: 221-226.

  60. Gow AJ, Luchsinger BP, Pawloski JR, Singel DJ, Stamler JS. The oxyhemoglobin reaction of nitric oxide. Proc Natl Acad Sci USA 1999; 96: 9027-9032.

  61. Ghittoni G, Valentini G, Spada C, et al. Hepatopulmonary syndrome. A review of the literature: Panminerva Med 2003; 45(2): 95-98.

  62. Sztrymf B, Rabiller A, Nunes H, Savale L, Lebrec D, Le Pape A, de Montpreville V, Mazmanian M, M Humbert, P Hervé. Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats. Eur Respir J 2004; 23: 752-758.

  63. Zhang M, Luo B, Chen SJ, Abrams GA, Fallon MB. Endothelin-1 stimulation of endothelial nitric oxide synthase in the pathogenesis of hepatopulmonary syndrome. Am J Physiol Gastrointest Liver Physiol 1999; 277: 944-952.

  64. Luo B, Liu L, Tang L, et al. Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: a potential mechanism in experimental hepatopulmonary syndrome. J Hepatol 2003; 38: 556-563.

  65. Zhang HY, Han DW, Wang XG, Zhao YC, Zhou X, Zhao HZ. Experimental study on the role of endotoxin in the development of hepatopulmonary syndrome. World J Gastroenterol 2005; 11(4): 567-572.

  66. Paul L, Steven G. Hemoglobin as a chariot for NO bioactivity. Nat Med 2002; 8: 657-658.

  67. Arguedas MR, Drake BB, Kapoor A, Fallon MB. Carboxyhemoglobin levels in cirrhotic patients with and without hepatopulmonary syndrome. Gastroenterology 2005; 128: 328-333.

  68. Rabiller A, Nunes H, Lebrec D, et al. Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome. Am J Respir Crit Care Med 2002; 166: 514-517.

  69. Ward A, Clissold S. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy. Drugs 1987; 34: 50-97.

  70. Krowka MJ, Cortese DA. Hepatoplumonary syndrome. Current concepts in diagnosis and therapeutic considerations. Chest 1994; 105: 1528-1537.

  71. Rodriguez-Roisin R, Agusti AGN, Roca J. The hepatopulmonary syndrome: new name, old complexities. Thorax 1992; 47: 897-902.

  72. Krowka MJ, Cortese DA. Hepatopulmonary syndrome: classification by arterial oxygenation and pulmonary angiographic appearance. Chest 1992; 102: 124.

  73. Ghittoni G, Valentini G, Spada C, et al. Hepatopulmonary syndrome. A review of the literature: Panminerva Med 2003; 45(2): 95-98

  74. Gomez F, Martinez-Palli G, Barbera J, Roca J, Navasa M, Rodriguez-Roisin R. Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome. Hepatology 2004; 40: 660-666.

  75. Seward JB, Hayes DL, Smith HC, et al. Platypnea-orthodeoxia: clinical profile, diagnostic work-up, management and report of seven cases. Mayo Clin Proc 1984; 59: 221.

  76. Krowka MJ, Dickson ER, Cortese DA. Hepatopulmonary syndrome. Clinical observations and lack of therapeutic response to somatostatin analogue. Chest 1993; 104: 515-521.

  77. Martinez GP, Barbera JA, Visa J, Rimola A, Pare JC, Roca J, Navasa M, Rodes J, Rodriguez-Roisin R. Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol 2001; 34: 651-657.

  78. Rodriguez-Roisin R, Roca J, Augusti AG, Mastai R, Wagner PD, Bosch J. Gas exchange and pulmonary vascular reactivity in patients with liver cirrhosis. Am Rev Respir Dis 1987; 135: 1085.

  79. Wang YW, Lin HC, et al. Recent Advances in Hepatopulmonary syndrome. J Chin Med Assoc 2005; 68(11): 500-536.

  80. Lima B, Martinelli A, Franca AV. Hepatopulmonary syndrome: pathogenesis, diagnosis and treatment Arq Gastroenterol 2004; 41(4): 250-258.

  81. Abrams GA, Sanders MK, Fallon MB. Utility of pulse oximetry in the detection of arterial hypoxemia in liver transplant candidates. Liver Transpl 2002; 8: 391-396.

  82. Arguedas M, Abrams GA, Krowka MJ, Fallon MB. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 2003; 37: 192-197.

  83. Castro M, Krowka MJ. Hepatopulmonary syndrome. A pulmonary vascular complication of liver disease. Clin Chest Med 1996; 17: 35-48.

  84. Hind CR, Wong CM. Detection of pulmonary arteriovenous fistulae in patients with cirrhosis by contrast 2D echocardiography. Gut 1981; 22: 1042-1045.

  85. Shub C, Tajik AJ, Seward JB, Dines DE. Detecting intrapulmonary right-to-left shunt with contrast echocardiography. Observations in a patient with diffuse pulmonary arteriovenous fistulas. Mayo Clin Proc 1976; 51: 81-84.

  86. Meltzer RS, Tickner EG, Popp RL. Why do the lungs clear ultrasonic contrast? Ultrasound Med Biol 1980; 6: 263-269.

  87. Vedrinne JM, Duperret S, Bizollon T, Magnin C, Motin J, Trepo C, Ducerf C. Comparison of transesophageal and transthoracic contrast echocardiography for detection of an intrapulmonary shunt in liver disease. Chest 1997; 111: 1236-1240.

  88. Lima BL, Franca AV, Pazin-Filho A, et al. Frequency, clinical characteristics, and respiratory parameters of hepatopulmonary syndrome. Mayo Clin Proc 2004; 79: 42.

  89. Krowka MJ, Cortese DA. Pulmonary aspects of liver disease and liver transplantation. Clin Chest Med 1989; 10: 593-616.

  90. Lee KN, Lee HJ, Shin WW, Webb WR. Hypoxemia and liver cirrhosis (hepatopulmonary syndrome) in eight patients: comparison of the central and peripheral pulmonary vasculature. Radiology 1999; 211: 549-553.

  91. Katsuta Y, Honma H, Zhang X, Ohsuga M, Komeichi H, Shimizu S, et al. Pulmonary blood transit time and impaired arterial oxygenation in patients with chronic liver disease. J Gastroenterol 2005; 40: 57-63.

  92. Lange PA, Stoller JK. The hepatopulmonary syndrome: effect of liver transplantation. Clin Chest Med 1996; 17: 115-123.

  93. Krowka MJ, Porayko MK, Plevak DJ, Pappas SC, Steers JL, Krom RA, Wiesner RH. Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review. Mayo Clin Proc 1997; 72: 44-53.

  94. Philit F, Wiesendanger T, Gille D, Boillot O, Cordier J. Late resolution of hepatopulmonary syndrome after liver transplantation. Respiration 1997; 64: 173-175.

  95. Mandell MS, Groves BM, Duke J. Progressive plexogenic pulmonary hypertension following liver transplantation. Transplantation 1995; 59: 1488-1490.

  96. Abrams GA, Rose K, Fallon MB, et al. Hepatopulmonary syndrome and venous emboli causing intracerebral hemorrhages after liver transplantation: a case report. Transplantation 1999; 68: 1-3.

  97. Scott V, Mira A, Kang Y, et al. Reversibility of the hepatopulmonary syndrome by orthotopic liver transplantation. Transplant Proc 1993; 25: 1787-1788.

  98. Meyers C, Low L, Kaufman L, Druger G, Wong LL. Trendelenburg positioning and continuous lateral rotation improve oxygenation in hepatopulmonary syndrome after liver transplantation. Liver Transpl Surg 1998; 6: 510-512.

  99. Durand P, Baujard C, Grosse AL, Gomola A, Debray D, Dousset B, Devictor D. Reversal of hypoxemia by inhaled nitric oxide in children with severe hepatopulmonary syndrome, type 1, during and after liver transplantation. Transplantation 1998; 65: 437-439.

  100. Henrion J, Schapira M, Luwaert R, Colin L, Delannoy A, Heller FR. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine (Baltimore) 2003; 82: 392-406.

  101. Abrams GA, Fallon MB. Treatment of hepatopulmonary syndrome with Allium sativum (garlic): a pilot trial. J Clin Gastroenterol 1998; 27: 232-235.

  102. Song JY, Choi JY, Ko JT, Bae EJ, Kim HS, Noh CI. Long-term aspirin therapy for hepatopulmonary syndrome. Pediatrics 1996; 97: 917-920.

  103. Caldwell SH, Jeffers LJ, Narula OS, Lang LA, Ready KR, Schiff R. Ancient remedies revisited: does Allium sativum (garlic) palliate the hepatopulmonary syndrome? J Clin Gastroenterol 1992; 15: 248-250.

  104. Anel RM, Sheagren JN. Novel presentation and approach to management of hepatopulmonary syndrome with use of antimicrobial agents. Clin Infect Dis 2001; 32: E131-E136.




2020     |     www.medigraphic.com